OmniAsset
Get app

OmniAsset › Mutual funds › HDFC Pharma and Healthcare Fund

HDFC Pharma and Healthcare Fund

Sectoral / Thematic fund benchmarked to BSE Healthcare Index (TRI). Every figure below is read from one dated snapshot; what the snapshot cannot prove is left out, never estimated.

Latest NAV2 Sep 202621.673
CategorySectoral / Thematic
PlanRegular · Growth
Launched14 Sep 2023
Risk labelthe scheme's own riskometerVery High Risk
Legal benchmarkSEBI Tier-1BSE Healthcare Index (TRI)
Expense ratiodirect plan, a year · stated maximum, from the scheme document2.16%
AUM₹1,494 Cr
Growth of ₹10,000₹21,7494 Oct 2023 to 2 Sep 2026
₹21,927₹18,916₹15,906₹12,896₹9,886Oct 2023Jun 2024Mar 2025Dec 2025Sep 2026
₹21,749 (+30.6% a year) HDFC Pharma and Healthcare Fund

Performance (trailing, annualised)

1Y annualised27.49%

Point-to-point from the fund's own published NAV; a period the history does not span is left out.

SIP returns

SIP 1Y (₹10,000 a month)invested ₹1,20,000 → worth ₹1,45,00240.60%

₹10,000 on the first of every month, valued at the latest NAV, as an annualised rate (XIRR).

Calendar years

Calendar 202450.33%
Calendar 20251.22%

Rolling returns

Rolling 1Y · average99 windows since 4 Oct 202422.92%
Rolling 1Y · median20.20%
Rolling 1Y · worst window0.85%
Rolling 1Y · best window63.68%
Rolling 1Y · windows positive100%

Every window of that length in the published history, so one lucky start date cannot flatter the fund.

Risk

Volatility (3Y)14.04%
Downside deviation (3Y)9.70%
Maximum drawdown-15.07%

Management

Fund managerMr. Nikhil Mathur, Mr. Dhruv Muchhal
Managing since3 Sep 2026

Related

Source: the OmniAsset signed reference snapshot, as of 4 Sep 2026. Figures are deterministic; missing data is withheld, never estimated. See methodology and data sources. Not investment advice.

Research this fund and compare it — on your device.

Get OmniAsset on Google Play The mutual fund tracker